1,671
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Effectiveness of the rehabilitation for addicted prisoners trust (RAPt) programme

, , , &
Pages 254-261 | Received 26 Nov 2013, Accepted 11 Mar 2014, Published online: 23 Apr 2014
 

Abstract

The Rehabilitation for Addicted Prisoners Trust (RAPt) Programme, the largest provider of intensive prison-based drug treatment in the UK, addresses both substance dependence and criminal behaviour through a comprehensive model. This study examined recidivism in a group of male prisoners who completed the RAPt programme (n = 352), a group of male prisoners who did not complete (n = 355) the programme, and a third comparison group of male prisoners who completed another in-prison drug treatment programme (n = 232). 12-month post-release recidivism data for the three groups were assessed with multivariate logistic regression in relation to age, race/ethnicity, length of sentence, prisoners’ drugs of choice, and prisoners’ primary offence for imprisonment. Results indicated that RAPt completers were less likely to re-offend within one year of prison release compared to the Comparison completers and prisoners who started but did not complete RAPt. Prisoners’ drugs of choice were also associated with re-offence with those treated for heroin or cocaine (crack or powder) use being more likely to re-offend compared with those treated for use of any other drugs. Finally, the type of offence for which prisoners were convicted was also a prominent factor with those sentenced for a property offence more likely to reoffend within one year compared to those convicted of a non-property offence. These findings demonstrate the effectiveness of the RAPt programme and identify prisoners with heroin or cocaine dependence at highest risk for recidivism. Programme enhancements may address the additional risk among prisoners who identified heroin or cocaine use as their primary drug of choice.

Declaration of interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.